Search

Search Constraints

You searched for: Author/Creator Protas, Hillary D.

Search Results

1. A new flortaucipir PET biomarker based on graph theory for early detection of CTE in former American football players. (20th December 2022)

2. A novel longitudinal approach in individual subjects to investigate the movement of tau over time using graph theory in clinical and preclinical stages of Alzheimer's disease: Neuroimaging / New imaging methods. (7th December 2020)

3. Associations between different FDG PET indices and clinical ratings in cognitively unimpaired older adults. (31st December 2021)

4. Baseline demographic, clinical, and cognitive characteristics of the Alzheimer's Prevention Initiative (API) Autosomal‐Dominant Alzheimer's Disease Colombia Trial. Issue 7 (17th May 2020)

5. CSF amyloid‐beta, tau, and neurodegenerative and inflammatory biomarkers in cognitively unimpaired late middle‐aged and older adult APOE ε4 homozygotes, heterozygotes, and non‐carriers from the Arizona APOE Cohort. (31st December 2021)

6. PET evidence of preclinical cerebellar amyloid plaque deposition in autosomal dominant Alzheimer's disease: Neuroimaging / imaging and genetics. (7th December 2020)

7. Plasma amyloid‐beta42/40 ratio as biomarker of cerebral amyloidosis in cognitively unimpaired APOE‐e4 homozygotes, heterozygotes and non‐carriers: Biomarkers (non‐neuroimaging) / plasma/serum/urine biomarkers. (7th December 2020)

8. Plasma neurofilament light chain in cognitively unimpaired late middle‐aged & older adult APOE ε4 homozygotes, heterozygotes, & non‐carriers from the Arizona APOE Cohort. (20th December 2022)

9. Reproductive health data and its relationship to baseline brain imaging and cognitive measurements in cognitively unimpaired female PSEN1 E280A mutation carriers and non‐carriers from the API ADAD Trial. (20th December 2022)

10. Sex differences in blood‐based biomarkers in individuals with autosomal dominant Alzheimer's disease. (1st February 2022)